These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3957485

  • 1. Determination of isoniazid half-life from salivary samples.
    Suryawati S, Santoso B.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):18-22. PubMed ID: 3957485
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of metronidazole in saliva.
    Mustofa, Suryawati S, Santoso B.
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):474-8. PubMed ID: 1813432
    [Abstract] [Full Text] [Related]

  • 3. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM, Mayet AY, Ayoola EA, Bawazir SA, Al-Faleh FZ, Al-Wazzan A.
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
    Allonen H, Iisalo E, Kangas L, Lammintausta R, Salonen M.
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
    [Abstract] [Full Text] [Related]

  • 6. A single sample saliva test to determine acetylator phenotype.
    Hutchings AD, Routledge PA.
    Br J Clin Pharmacol; 1996 Nov; 42(5):635-7. PubMed ID: 8951197
    [Abstract] [Full Text] [Related]

  • 7. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y, Ishizaki T, Sasaki T, Koya G, Matsuyama K, Iguchi S.
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A simple method for determining acetylator phenotype using isoniazid.
    Hutchings A, Routledge PA.
    Br J Clin Pharmacol; 1986 Sep; 22(3):343-5. PubMed ID: 3768246
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Time course of free and N4-acetylated sulfapyridine concentrations in the plasma and saliva of man after sulfasalazine (salicylazosulfapyridine) administration: preliminary findings.
    Bates TR, Blumenthal HP, Pieniaszek HJ.
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):183-9. PubMed ID: 9675
    [Abstract] [Full Text] [Related]

  • 15. Disopyramide concentrations in saliva.
    Aitio ML, Virtanen R, Lammintausta R.
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [Abstract] [Full Text] [Related]

  • 16. Isoniazid pharmacokinetics in children according to acetylator phenotype.
    Rey E, Gendrel D, Treluyer JM, Tran A, Pariente-Khayat A, d'Athis P, Pons G.
    Fundam Clin Pharmacol; 2001 Oct; 15(5):355-9. PubMed ID: 11903505
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH, Smith CV, Todd EL, Mitchell JR.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [Abstract] [Full Text] [Related]

  • 18. [Determination of acetylator phenotype of isoniazid by superimposed sinusodial tension polarography].
    Vallon JJ, Badinand A, Bichon C.
    Eur J Toxicol Environ Hyg; 1976 Dec; 9(3):155-64. PubMed ID: 954852
    [Abstract] [Full Text] [Related]

  • 19. Acetylation phenotype in rheumatoid arthritis.
    Oka M, Seppälä O.
    Scand J Rheumatol; 1978 Dec; 7(1):29-30. PubMed ID: 675172
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.